MEKAWIRE
United StatesSeries A

Warp Sciences

US chemistry contract research organization that combines medicinal chemists, AI and lab robotics to make research compounds for biotech and pharma drug discovery teams.

Warp Sciences has raised $215M across 1 disclosed round since Oct 22, 2026; the latest round, Series A, was announced on Oct 22, 2026. Data as of Oct 23, 2026.

Headquartered in United States.

Website

Latest from MEKAWIRE

InvestorTypeCountryRoundsLedFirstLatest
Lightspeed Venture PartnersVenture capital—112026-10-222026-10-22
01 AdvisorsVenture capital—102026-10-222026-10-22
Angular VenturesVenture capital—102026-10-222026-10-22
ConvictionVenture capital—102026-10-222026-10-22
Gigascale CapitalVenture capital—102026-10-222026-10-22
IVPVenture capital—102026-10-222026-10-22
Innovation EndeavorsVenture capital—102026-10-222026-10-22
Lowercarbon CapitalVenture capital—102026-10-222026-10-22
Lux CapitalVenture capital—102026-10-222026-10-22
Matter Venture PartnersVenture capital—102026-10-222026-10-22
MayfieldVenture capital—102026-10-222026-10-22
Menlo VenturesVenture capital—102026-10-222026-10-22
Moxxie VenturesVenture capital—102026-10-222026-10-22
Premji InvestVenture capital—102026-10-222026-10-22
Scribble VenturesVenture capital—102026-10-222026-10-22
SignalFireVenture capital—102026-10-222026-10-22
StandardVenture capital—102026-10-222026-10-22
Uncork CapitalVenture capital—102026-10-222026-10-22
Zero Shot FundVenture capital—102026-10-222026-10-22

Related companies